Region‐dependent attenuation of μ opioid receptor‐mediated G‐protein activation in mouse CNS as a function of morphine tolerance
- 1 August 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (8) , 1324-1333
- https://doi.org/10.1038/sj.bjp.0707328
Abstract
Chronic morphine administration produces tolerance in vivo and attenuation of μ opioid receptor (MOR)-mediated G-protein activation measured in vitro, but the relationship between these adaptations is not clear. The present study examined MOR-mediated G-protein activation in the CNS of mice with different levels of morphine tolerance. Mice were implanted with morphine pellets, with or without supplemental morphine injections, to induce differing levels of tolerance as determined by a range of MOR-mediated behaviours. MOR function was measured using agonist-stimulated [35S]guanylyl-5′-O-(γ-thio)-triphosphate ([35S]GTPγS) and receptor binding throughout the CNS. Morphine pellet implantation produced 6-12-fold tolerance in antinociceptive assays, hypothermia and Straub tail, as measured by the ratio of morphine ED50 values between morphine-treated and control groups. Pellet implantation plus supplemental injections produced 25-50-fold tolerance in these tests. In morphine pellet-implanted mice, MOR-stimulated [35S]GTPγS binding was significantly reduced only in the nucleus tractus solitarius (NTS) and spinal cord dorsal horn in tissue sections from morphine pellet-implanted mice. In contrast, MOR-stimulated [35S]GTPγS binding was significantly decreased in most regions examined in morphine pellet+morphine injected mice, including nucleus accumbens, caudate-putamen, periaqueductal gray, parabrachial nucleus, NTS and spinal cord. Tolerance and the regional pattern of apparent MOR desensitization were influenced positively by the level of morphine exposure. These results indicate that desensitization of MOR-mediated G-protein activity is more regionally widespread upon induction of high levels of tolerance, suggesting that this response contributes more to high than low levels of tolerance to CNS-mediated effects of morphine. British Journal of Pharmacology (2007) 151, 1324–1333; doi:10.1038/sj.bjp.0707328Keywords
This publication has 54 references indexed in Scilit:
- Changes in Accumbal and Pallidal pCREB and ΔFosB in Morphine-Sensitized Rats: Correlations with Receptor-Evoked Electrophysiological Measures in the Ventral PallidumNeuropsychopharmacology, 2005
- Antinociceptive and nociceptive actions of opioidsJournal of Neurobiology, 2004
- Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in VivoMolecular Pharmacology, 2002
- Acute and Chronic Effects of Opioids on δ and μ Receptor Activation of G Proteins in NG108‐15 and SK‐N‐SH Cell MembranesJournal of Neurochemistry, 1997
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- Opioid receptor-coupled second messenger systemsLife Sciences, 1991
- Morphine-induced desensitization and down-regulation at mu-receptors in 7315c pituitary tumor cellsLife Sciences, 1989
- Morphine-induced Straub tail reaction and spinal catecholamine metabolite content: Antagonism of naloxone to morphine-induced effects in mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1978
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976